Leonard Calabrese, DO
Board Certified Rheumatologist and the Head, Section of Clinical Immunology Department of Rheumatic & Immunologic Disease
Cleveland Clinic
Cleveland, OH, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Chemocentryx: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Jansen: Advisor or Review Panel Member (Ongoing); Novartis: Consultant (Ongoing); UCB: Consultant (Ongoing)
Historically, the understanding of polymyalgia rheumatica (PMR) has been limited, but recent developments provide us with a better perspective on the inflammatory processes that drive PMR, including cytokines such as interleukin-6 (IL-6). Please join Dr. Leonard Calabrese as he discusses the pathophysiology of PMR and the central role of IL-6 and other cytokines driving PMR progression. This program will also highlight factors which may interfere with diagnosing PMR and the limited options for management.
Developed & offered by Sanofi & Regeneron.
